Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.82 - $3.16 $360,287 - $625,553
197,960 New
197,960 $475,000
Q4 2022

Feb 14, 2023

BUY
$11.0 - $21.45 $952,259 - $1.86 Million
86,569 New
86,569 $1.02 Million
Q1 2022

May 16, 2022

SELL
$36.48 - $52.22 $470,920 - $674,107
-12,909 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$33.11 - $55.01 $427,416 - $710,124
12,909 New
12,909 $561,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $443M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.